SAT-115-Fondaparinux vs low molecular weight heparin in the treatment of non malignant portal vein thrombosis in patients with cirrhosis

Authors :: Salvatore Piano
Patrizia Burra
Alberto Zanetto
Marco Senzolo
Marta Tonon
Paolo Simioni
Giancarlo Bombonato
Silvia Tonello
Paolo Angeli
David Sacerdoti
Source :: Journal of Hepatology. 70:e681
Publication Year :: 2019
Publisher :: Elsevier BV, 2019.

Subjects :: medicine.medical_specialty
Cirrhosis
Hepatology
business.industry
medicine.drug_class
Low molecular weight heparin
Non malignant
medicine.disease
Fondaparinux
Gastroenterology
Portal vein thrombosis
Internal medicine
medicine
In patient
business
medicine.drug

Full Text Access

Tools